Skip to main content
. 2018 May 30;315(4):F942–F953. doi: 10.1152/ajprenal.00129.2018

Table 5.

Predicted impact of parathyroid hormone on PO4 transport

JPO4, pmol·min−1·mm−1 per nephron
Filtered Load, pmol/min per nephron %Reabsorption Net Transcellular Paracellular
Base case 78.0 79.2 5.62 7.14 −1.52
75% inhibition of Na+-PO4 transporters 78.0 54.7 3.88 2.69 +1.19
90% inhibition of Na+-PO4 cotransporters 78.0 46.2 3.27 1.26 +2.01
NHE3 inhibition* 78.0 94.8 6.73 9.92 −3.19
NHE3 inhibition* and 75% inhibition of Na+-PO4 cotransporters 78.0 55.5 3.93 4.16 −0.23
NHE3 inhibition* and 90% inhibition of Na+-PO4 cotransporters 78.0 38.6 2.73 1.97 +0.76
20% reduction in SNGFR 62.4 67.1 3.81 4.47 −0.66
20% reduction in SNGFR, NHE3 inhibition* and 75% inhibition of Na+-PO4 cotransporters 62.4 47.7 2.70 2.59 +0.11
20% reduction in SNGFR, NHE3 inhibition* and 90% inhibition of Na+-PO4 cotransporters 62.4 35.8 2.03 1.22 +0.81

JPO4, flux of PO4 (HPO42+ H2PO4); NHE3, Na+/H+ exchanger type 3; SNGFR, single-nephron glomerular filtration rate. Fractional inhibition of Na+-PO4 cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 is taken to be the same.

*

Parathyroid hormone is assumed to reduce basal expression of NHE3 and Na+-K+-ATPase by 75% and 25%, respectively.